TY  - JOUR
AU  - Riesco Martínez, María Carmen
AU  - Lamas Paz, Arantza
AU  - Rodríguez Gil, Yolanda
AU  - Soldevilla Navarro, Beatriz
AU  - García Carbonero, Rocío
PY  - 2024
DO  - 10.1038/s41467-024-50969-8
SN  - 2041-1723
UR  - https://hdl.handle.net/20.500.14352/117195
T2  - Nature Communications
AB  - The prognosis of patients with advanced high-grade (G3) digestive neuroendocrine neoplasms (NENs) is rather poor. The addition of immune checkpoint inhibition to platinum-based chemotherapy may improve survival. NICE-NEC (NCT03980925) is a single-arm,...
LA  - eng
PB  - Nature Portfolio
KW  - Cancer immunotherapy
KW  - Immunotherapy
KW  - Neuroendocrine cancer
TI  - Nivolumab plus platinum-doublet chemotherapy in treatment-naive patients with advanced grade 3 Neuroendocrine Neoplasms of gastroenteropancreatic or unknown origin: The multicenter phase 2 NICE-NEC trial (GETNE-T1913)
TY  - journal article
VL  - 15
ER  -